Revisionist History The Future of Healthcare Technology with Eli Lilly and Company's Diogo Rau
34 snips
Feb 6, 2025 Diogo Rau, Chief Information and Digital Officer at Eli Lilly and Company, discusses how technology is revolutionizing healthcare. He highlights Lilly Direct, an innovative tool for chronic care management connecting patients and providers. Rau shares insights from his transition from tech to pharma, emphasizing customer-centric approaches that improve healthcare delivery. He reveals strategies to combat counterfeit medications using advanced tech like NFC tags. Lastly, he explores the impact of AI on drug discovery and rapid medication delivery, transforming patient experiences.
AI Snips
Chapters
Transcript
Episode notes
Unusual Career Move
- Diogo Rau, after a long career at Apple, transitioned to Eli Lilly.
- This is unusual; Rau only knows about five people who've made similar moves.
Long-Term Vision
- The life sciences industry operates on significantly longer timescales than the tech industry.
- Eli Lilly discusses revenue forecasts up to nine years out, while tech companies rarely look beyond 18 months.
2036 Launch
- At a recent meeting, Eli Lilly discussed a product launch scheduled for 2036.
- Tech companies rarely plan that far ahead, demonstrating the pharmaceutical industry's long-term focus.